Publicaciones Unidad de Investigaciones CMR

Artículos:

Characteristics associated with Covid-19 in patients with Rheumatic Disease in Latin America: data from the Covid-19 Global Rheumatology Alliance physician-reported registry. Global Rheumatology. 2020. https://www.globalrheumpanlar.org/node/254
Women’s journey in Mexican rheumatology. Comment on ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga et al. Ann Rheum. 2020 https://ard.bmj.com/content/early/2020/08/04/annrheumdis-2020-218541
Navigating COVID-19 in the Developing World. Clinical Rheumatology. 2020. https://link.springer.com/article/10.1007/s10067-020-05159-4

Resúmenes en congresos:

Eular 2020/2021

The impact of age on discontinuation of biologic DMARDs in patients with rheumatoid arthritis. Ann Rheum Dis 2021;80:559. EULAR scientific meeting 2021. https://ard.bmj.com/content/80/Suppl_1/559.2
Mortality of covid-19 in patients with rheumatic diseases: comparison to the general population in Mexico. Ann Rheum Dis 2021;80:905. EULAR scientific meeting 2021. https://ard.bmj.com/content/80/Suppl_1/905.2
Factors associated with mortality in patients with rheumatic diseases and covid-19 in Mexico. Ann Rheum Dis 2021;80:904. EULAR scientific meeting 2021. https://ard.bmj.com/content/80/Suppl_1/904.1
Safety of biosimilar etanercept in the treatment of rheumatic diseases: data from the Mexican Adverse Events Registry (BIOBADAMEX). EULAR scientific meeting 2020. https://ard.bmj.com/content/79/Suppl_1/1905.1
Gender differences of rheumatic diseases in Mexican population: data from the Mexican Biologics Registry. EULAR scientific meeting 2020. https://ard.bmj.com/content/79/Suppl_1/874

ACR 2020

Impact of COVID-19 Pandemic on the Rheumatology Practice in Mexico: Mexican College of Rheumatology Survey [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10).
Gender and Discontinuation of Biologic DMARDs in Patients with Rheumatoid Arthritis: Data from the Mexican Biologics Registry [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10).